CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE
Enters into Strategic Transaction, unlocking $100 million in value Sharpens focus on Orphan Drug candidates to address unmet medical needs NASHVILLE, Tenn., May... Read more.
OnPoint Solutions Introduces “The Upper Hand Glove” Ahead of Border Security Expo 2026
Metal-detecting glove with cut and puncture resistance improves speed, accuracy, and safety in high-volume security environments, Booth #246. PHOENIX, May 5, 2026... Read more.
Fountain Digital Now Fully Qualified Yardi® Ecosystem Partner
Interface is available now to Fountain Digital clients using Yardi Voyager® CLEVELAND, May 5, 2026 /PRNewswire/ — Fountain Digital today announced it is... Read more.
Central New Mexico Community College Anchors National Launch of the Technician Economy™
The new economic framework intends to better convert innovation into operating capacity and economic mobility ALBUQUERQUE, N.M., May 5, 2026 /PRNewswire/ —... Read more.
Bristow Group Reports First Quarter 2026 Results
HOUSTON, May 5, 2026 /PRNewswire/ — First Quarter Highlights Total revenues of $388.7 million in Q1 2026 compared to $377.3 million in Q4 2025 Net income... Read more.
Nelnet Campus Commerce Named Top Higher Education Payment Solutions Provider by Education Technology Insights
LINCOLN, Neb., May 5, 2026 /PRNewswire/ — Nelnet Campus Commerce, a division of Nelnet, Inc. (NYSE: NNI), announced it has been named Top Higher Education... Read more.
Cboe Global Markets Reports Trading Volume for April 2026
CHICAGO, May 5, 2026 /PRNewswire/ — Cboe Global Markets, Inc. (Cboe: CBOE), a leading global markets operator and pioneer in equity derivatives, today reported... Read more.
Hoth Therapeutics Secures European Authorization in Spain for HT-001 Phase 2a Trial as Interim Data Show Strong Efficacy in Cancer Patients
Regulatory Clearance in Spain Advances Randomized, Placebo-Controlled Study; Patients Show Meaningful Reductions in EGFR-Inhibitor Skin Toxicities with No Treatment... Read more.
Factor Bioscience to Deliver Seven Presentations at the American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting
-Factor advances next-generation allogeneic and in vivo CAR-T cell therapy programs -Presentations will include latest data from Factor’s IL12-expressing iMacrophages... Read more.
Dave Reports First Quarter 2026 Financial Results
Q1 Revenue Grows 47% Y/Y to $158.4 Million Driven by Continued MTM Growth and ARPU Expansion 28-DPD Rate Reaches Record Q1 Low of 1.69%, While Net Monetization... Read more.